ALTERATIONS IN CELLULAR PROCESSES
Respond to at least two of your colleagues on 2 different days and respectfully agree or disagree with your colleague’s assessment and explain your reasoning. In your explanation, include why their explanations make physiological sense or why they do not. I will post 2 of my colleagues posts
1st one
Scenario
The patient is a 48-year-old male with complaints of stiffness in his fingers that migrates to his upper arm joints and increased fatigue over the last few months. The patient works in a bank and types frequently. He commented that he thought he could have carpal tunnel syndrome, but the fatigue was beginning to worry him. The patient reports a family history of rheumatoid arthritis. He is currently taking Motrin for pain which partially relieves the symptoms. He rates his pain a 5/10 at present, aching in both hands. The patient’s vital signs are 120/80, Pulse 78, Res 16, Temp 100.1 F. He denies any recent weight changes. Physical exam reveals: Edema to 4th and 5th PIP joints bilaterally with tenderness in the same joints. His grip strength is decreased bilaterally. No edema of knees or ankles was noted.
Role of Genetics
In the given scenario, the Patient seems to be having acute onset of Rheumatoid arthritis and some exacerbation. Genetic factors show that he has a history of RA in the family, but his environmental factor could also seem like Carpel tunnel syndrome. The only reason RA is a better possibility is because of the traveling pain to other joints.
Cell Processes and Physiological Response
The physiologic response to the stimulus presented in the scenario, namely the joint inflammation and pain, involves various immune cells and inflammatory mediators (McInnes & Schett, 2017). In RA, immune cells such as T cells and B cells infiltrate the synovial tissue, leading to the production of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-alpha) and interleukins. These cytokines promote inflammation, which causes joint swelling, pain, and eventual damage to the cartilage and bone.
Cells involved in this process include T cells which activate B cells and produce pro-inflammatory cytokines. These cells trigger the production of autoantibodies, including rheumatoid factor and anti-cyclic citrullinated peptide antibodies, which contribute to joint inflammation and damage. The macrophages then release inflammatory cytokines and enzymes that degrade joint tissue. Lastly, Synovial fibroblasts start to invade surrounding tissue, contributing to synovial inflammation and joint destruction. (McInnes & Schett, 2017)
Symptoms and Diagnosis
Symptoms of fatigue along with certain tests can confirm RA such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels from inflammation and a rheumatoid factor (RF) test and anti-cyclic citrullinated peptide (anti-CCP) antibody test would confirm the diagnosis of RA. (McInnes & Schett, 2017)
Further assessments with imaging studies like X-rays or ultrasound may help in assessing joint damage and inflammation. Given the patient’s temperature of 100.1°F, there’s a possibility of an underlying infection or inflammation exacerbating the symptoms of RA. This aspect should be closely monitored, and if the fever persists or worsens, blood culture or joint fluid aspiration is another possible test. In the meantime, symptomatic relief with nonsteroidal anti-inflammatory drugs (NSAIDs) like Motrin can be continued, but disease-modifying antirheumatic drugs (DMARDs) such as methotrexate or biologic agents may be necessary for long-term management of RA. (McInnes & Schett, 2017)
Other Factors besides Genetics
Regarding other factors, RA is more common in females than males, with women being two to three times more likely to develop the condition. This difference in gender prevalence may influence the clinical presentation and response to treatment. For example, women with RA may experience more severe symptoms and joint damage compared to men. (Deane & Buckner, 2010) Factors such as smoking, infections, hormonal changes, and exposure to certain pollutants or toxins may contribute to the development of RA, particularly in genetically susceptible individuals (Smolen et al., 2016).
Resources
Deane, Kevin D., and Jane H. Buckner. “Genetic and environmental factors in the pathogenesis of rheumatoid arthritis.” Rheumatic Disease Clinics 36, no. 2 (2010): 263-277.
McInnes, Iain B., and Georg Schett. “Pathogenetic insights from the treatment of rheumatoid arthritis.” The Lancet 389, no. 10086 (2017): 2328-2337.
Smolen, Josef S., Daniel Aletaha, and Iain B. McInnes. “Rheumatoid arthritis.” The Lancet 388, no. 10055 (2016): 2023-2038.
2nd one
Based on the scenario, the patient might have Rheumatoid arthritis. It is a chronic inflammatory disorder that typically affects the small joints in the hands and feet. Unlike osteoarthritis, which causes wear-and-tear damage, rheumatoid arthritis affects the lining of joints, causing painful swelling that can eventually result in bone erosion and joint deformity (Smolen et al., 2016).
Genetic risk factors contribute significantly to the development of rheumatoid arthritis (RA). These include a family history of RA, with genetic predisposition playing a substantial role in familial clustering (Deane et al., 2017). Additionally, being female increases the risk of RA, hinting at hormonal or genetic influences. Specific genetic variants within the HLA gene region, known as the shared epitope, are strongly associated with RA risk, particularly in individuals with autoantibody-positive RA (Padyukov, 2022). Environmental factors also play a significant role, such as exposure to tobacco smoke, especially in those with genetic susceptibility. Moreover, there is growing interest in the role of mucosal inflammation and microbial factors, suggesting a potential link between the gut microbiome and immune dysregulation in RA development.
The patient presents symptoms related to rheumatoid arthritis: migratory joint stiffness and systemic symptoms like fatigue and low-grade fever point towards an inflammatory process in RA. Low-grade fever (Temperature 100.1°F) is also associated with systemic inflammatory conditions like RA.
The physiologic response observed in this scenario suggests a possible inflammatory process, likely indicative of rheumatoid arthritis (RA). RA is an autoimmune disorder characterized by inflammation of the synovial joints, leading to pain, stiffness, and fatigue. The patient’s symptoms of migrating stiffness in the fingers and upper arm joints, along with bilateral hand pain and decreased grip strength, align with typical manifestations of RA. Additionally, the presence of edema and tenderness in the fourth and fifth proximal interphalangeal (PIP) joints, without the involvement of other joints, further supports the suspicion of RA (Smolen et al., 2016). The family history of rheumatoid arthritis also increases the likelihood of this diagnosis. The patient’s vital signs, including a low-grade fever, suggest systemic and joint inflammation in RA. Overall, the combination of symptoms, physical exam findings, and history support the physiologic response of an inflammatory process characteristic of rheumatoid arthritis in this patient.
In rheumatoid arthritis (RA), various cell types play pivotal roles in the inflammatory process. Synovial fibroblasts, lining the joints’ synovial membrane, become activated, generating pro-inflammatory cytokines and enzymes contributing to joint degradation. T cells are integral to the immune response, activated by antigens and releasing pro-inflammatory cytokines, fueling the inflammatory cascade (Padyukov, 2022). B cells produce autoantibodies like rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies, targeting self-antigens and contributing to autoimmunity. Macrophages release pro-inflammatory cytokines and participate in tissue damage through phagocytosis and enzyme release (Deane et al., 2017). Neutrophils recruited to the inflamed site release reactive oxygen species and proteolytic enzymes, exacerbating tissue damage. Additionally, endothelial cells lining synovial blood vessels activate, increasing permeability and facilitating inflammatory cell recruitment. These interplaying cells perpetuate inflammation and joint destruction in RA, prompting the development of therapies targeting these pathways to modulate the immune response and enhance RA patient outcomes.
Genetic factors may interact differently with gender, influencing disease susceptibility and severity. For example, specific genetic variants within the HLA gene region, like the shared epitope, may confer a higher risk of RA in women than men (Deane et al., 2017). Therefore, considering gender as a characteristic could lead to a more nuanced understanding of RA pathogenesis, prognosis, and treatment strategies, potentially impacting the selection and effectiveness of therapeutic interventions tailored to individual patients.
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
